USV Limited manufactures Injection for Reversible Inhibition of Platelet Aggregation. USV Limited also offers various types of Generics, Active Pharmaceutical Ingredients and Biotherapeutics. The Injection for Reversible Inhibition of Platelet Aggregation, also known as Eptifibatide, is a cyclic heptapeptide that reversibly inhibits platelet aggregation by binding to A GP-IIb/IIIa receptor site on platelets. The Injection for Reversible Inhibition of Platelet Aggregation is produced by using a method based on solid phase peptide synthesis technology. The Injection for Reversible Inhibition of Platelet Aggregation is marketed under the brand name `CoroMax`.